Pasteurized Donor Human Milk for HIV-Exposed Infants: A Pilot Study

Launched by UNIVERSITY OF SASKATCHEWAN · Apr 24, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring the possibility of using Pasteurized Donor Human Milk (PDHM) for infants who have been exposed to HIV. PDHM is human milk that has been safely processed to kill any harmful germs while keeping its beneficial nutrients. The goal of this study is to see if feeding PDHM to HIV-exposed infants is a practical option and to understand any challenges that caregivers might face in using this milk. This research is important because it could provide a safer alternative to formula feeding, which is currently the standard for these infants.

To participate in this trial, you need to be at least 15 years old, either pregnant or a new parent living with HIV, and be the primary caregiver of an HIV-exposed infant. You should live near Saskatoon and have access to a household freezer. If you join, you can expect to provide feedback on your experience with PDHM and help researchers understand how to make this feeding option more accessible. The findings from this study could lead to better support for families in similar situations in the future.

Gender

ALL

Eligibility criteria

• • Inclusion criteria
• • ≥15 years of age
• • Pregnant or recently gave birth and living with HIV or is the primary caregivers of an HIV-exposed infant
• • Being followed by SHA Pediatric Infectious Disease
• • Saskatoon resident (living within \~25 km from the University of Saskatchewan)
• • Have a household freezer
• • Willing to participate